Welcome to CDC Stacks | Successful Treatment of Disseminated Acanthamoeba sp. Infection with Miltefosine - 16932 | Emerging Infectious Diseases
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
Successful Treatment of Disseminated Acanthamoeba sp. Infection with Miltefosine
  • Published Date:
    Nov 2008
  • Source:
    Emerg Infect Dis. 14(11):1743-1746.
Filetype[PDF - 300.53 KB]


Details:
No Related Documents.
You May Also Like:
  1. Successful Treatment of Disseminated Anncaliia algerae Microsporidial Infection With Combination Fumagillin and Albendazole
    Personal Author:
    Boileau, Mélissa; Ferreira, José; Ahmad, Imran; Lavallée, Christian; Qvarnstrom, Yvonne; Dufresne, Simon F.;
    Published:
    Jul 29 2016
    Source:
    Open Forum Infect Dis. 2016; 3(3).
    Description:
    Anncaliia algerae myositis is a life-threatening, emerging microsporidiosis among immunocompromised hosts. We report a case of disseminated A algerae infection in a man previously treated with alemtuzumab. Due to failure of albendazole-based therapy,...
    File Type:
    Filetype[PDF - 256.37 KB]
  2. Coming Soon
    Disseminated Acanthamoeba infection in a heart transplant recipient treated successfully with a miltefosine-containing regimen: case report and review of the literature
    Personal Author:
    Brondfield, MN; Reid, MR; Rutishauser, RL; Cope, JR; Tang, J; Ritter, JM; Matanock, A; Ali, I; Doernberg, SB; Hilts-Horeczko, A; DeMarco, T; Klein, L; Babik, JM;
    Published:
    Mar 06 2017
    Source:
    Transpl Infect Dis. 19(2).
    Description:
    Disseminated acanthamoebiasis is a rare, often fatal, infection most commonly affecting immunocompromised patients. We report a case involving sinuses, skin, and bone in a 60-year-old woman 5 months after heart transplantation. She improved with a c...
    Public Access
    Available on:
    April 01, 2018
  3. Coming Soon
    Successful Treatment of Prosthetic Joint Infection due to Vancomycin-resistant Enterococci with Tedizolid
    Personal Author:
    Si, Sheng; Durkin, Michael J.; Mercier, Maureen M.; Yarbrough, Melanie L.; Liang, Stephen Y.;
    Published:
    Mar 2017
    Source:
    Infect Dis Clin Pract (Baltim Md). 25(2):105-107.
    Description:
    Few antibiotic options exist for the management of infections due to vancomycin-resistant enterococci (VRE). We describe a case involving the safe and successful use of tedizolid, a new oxazolidinone, to treat VRE prosthetic joint infection.
    Public Access
    Available on:
    March 01, 2018
  4. Characterization of a New Pathogenic Acanthamoeba Species, A. byersi n. sp., Isolated from a Human with Fatal Amoebic Encephalitis
    Personal Author:
    Qvarnstrom, Yvonne; Nerad, Thomas A.; Visvesvara, Govinda S.;
    Published:
    2013 Nov-Dec
    Source:
    J Eukaryot Microbiol. 60(6):626-633.
    Description:
    Acanthamoeba spp. are free-living amoebae that are ubiquitous in natural environments. They can cause cutaneous, nasopharyngeal, and disseminated infection, leading to granulomatous amebic encephalitis (GAE) in immunocompromised individuals. In addit...
    File Type:
    Filetype[PDF - 596.20 KB]
  5. Successful Treatment of an Adolescent with Naegleria fowleri Primary Amebic Meningoencephalitis
    Personal Author:
    Linam, W. Matthew; Ahmed, Mubbasheer; Cope, Jennifer R.; Chu, Craig; Visvesvara, Govinda S.; da Silva, Alexandre J.; Qvarnstrom, Yvonne; Green, Jerril;
    Published:
    Feb 09 2015
    Source:
    Pediatrics. 135(3):e744-e748.
    Description:
    Naegleria fowleri is a thermophilic, free-living ameba that causes primary amebic meningoencephalitis. The infections are nearly always fatal. We present the third well-documented survivor of this infection in North America. The patient's surviv...
    File Type:
    Filetype[PDF - 470.15 KB]